Variability in strength of red yeast rice supplements purchased from mainstream retailers

被引:34
作者
Cohen, Pieter A. [1 ,2 ]
Avula, Bharathi [3 ]
Khan, Ikhlas A. [3 ]
机构
[1] Cambridge Hlth Alliance, Dept Med, Somerville, NJ USA
[2] Harvard Med Sch, Boston, MA USA
[3] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, Oxford, MS USA
关键词
Primary prevention; red yeast rice; DIETARY-SUPPLEMENTS; MASS-SPECTROMETRY; CITRININ; PRODUCTS;
D O I
10.1177/2047487317715714
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The United States Food and Drug Administration (FDA) has introduced manufacturing standards for dietary supplements, including red yeast rice, to assure their identity, purity, strength, and composition. One supplement commonly used to self-treat high cholesterol, red yeast rice, may contain monacolin K, an ingredient identical to prescription lovastatin. We examined whether FDA's manufacturing standards led to standard concentrations of the statin monacolin K in red yeast rice supplements. We analyzed 28 brands of red yeast rice supplements by ultra-high performance liquid chromatography-diode array detector-quadrupole time-of-flight mass spectrometry for monacolin K content. Monacolin K was not detected in two brands. In the 26 brands that contained monacolin K, the quantity ranged more than 60-fold from 0.09 to 5.48mg per 1200mg of red yeast rice. Following the manufacturers' recommendations for daily servings, the quantity of monacolin K consumed per day would range more than 120-fold from 0.09 to 10.94mg. Despite FDA manufacturing standards, strength and composition of red yeast rice supplements sold at mainstream retail stores in the United States remains unpredictable.
引用
收藏
页码:1431 / 1434
页数:4
相关论文
共 12 条
[1]   Muscle- and skeletal-related side-effects of statins: tip of the iceberg? [J].
Auer, Johann ;
Sinzinger, Helmut ;
Franklin, Barry ;
Berent, Robert .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (01) :88-110
[2]   Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application [J].
Avula, Bharathi ;
Cohen, Pieter A. ;
Wang, Yan-Hong ;
Sagi, Satyanarayanaraju ;
Feng, Wei ;
Wang, Mei ;
Zweigenbaum, Jerry ;
Shuangcheng, Ma ;
Khan, Ikhlas A. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 100 :243-253
[3]   Study on red fermented rice with high concentration of monacolin K and low concentration of citrinin [J].
Chen, FS ;
Hu, XQ .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2005, 103 (03) :331-337
[4]  
Dixon RP, 2014, WARNING LETT FLA 14
[5]  
Food and Drug Administration, 2007, FED REGISTER, V72, P34752
[6]   Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - A systematic review and meta-analysis [J].
Gerards, Maaike C. ;
Terlou, Ruben J. ;
Yu, Huixin ;
Koks, C. H. W. ;
Gerdes, V. E. A. .
ATHEROSCLEROSIS, 2015, 240 (02) :415-423
[7]   Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products Buyer Beware! [J].
Gordon, Ram Y. ;
Cooperman, Tod ;
Obermeyer, William ;
Becker, David J. .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (19) :1722-1727
[8]   An analysis of nine proprietary Chinese red yeast rice dietary supplements: Implications of variability in chemical profile and contents [J].
Heber, D ;
Lembertas, A ;
Lu, QY ;
Bowerman, S ;
Go, VLW .
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2001, 7 (02) :133-139
[9]   Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system [J].
Mazzanti, Gabriela ;
Moro, Paola Angela ;
Raschi, Emanuel ;
Da Cas, Roberto ;
Menniti-Ippolito, Francesca .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) :894-908
[10]   Symptomatic myopathy due to red yeast rice [J].
Mueller, Paul S. .
ANNALS OF INTERNAL MEDICINE, 2006, 145 (06) :474-475